Current Clinical Trials

Let us know if  you or someone you know is interested in participating in one of the Actively Recruiting Clinical Trials:

Actively Recruiting

Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson’s Disease 

The Parkinson’s Progression Markers Initiative 

Ongoing, But Not Actively Recruiting
A Prospective Randomized Placebo-Controlled Double-Blind Study Assessing Change in Olfactory Function After Initiation of Rasagiline in Idiopathic Parkinson's Disease  
A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects with
Treated Parkinson's Disease. Long-term Study - 1 
◊ ACP-103-015
A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the
Treatment of Psychosis in Parkinson’s Disease
National Parkinson Foundation Quality Improvement Initiative
Parkinson Associated Risk Factor Study:  Evaluating Potential Screening Tools for Parkinson's disease 
A Randomized, Placebo-Controlled, Multi-Center Study to Assess the Disease Modifying Potential of Transdermal NICotine in Early Parkinson's Disease in Germany and the USA


675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)